4.8 Article

A NIR-II-emitting gold nanocluster-based drug delivery system for smartphone-triggered photodynamic theranostics with rapid body clearance

期刊

MATERIALS TODAY
卷 51, 期 -, 页码 96-107

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.mattod.2021.09.022

关键词

NIR-II imaging; DFT calculation; Gold nanoclusters; Renal clearance; Smartphone; Photodynamic therapy

资金

  1. Engineering and Physical Sciences Research Council (EPSRC) [EP/K009567]
  2. EPSRC [EP/L000202, EP/R029431, EP/T022213]
  3. European Regional Development Fund (ERDF) via the Welsh Government
  4. Department of Defense/Air Force Office of Scientific Research Military Photomedicine Program [FA9550-17-1-0277]
  5. American Cancer Society [132998-MBG-18-208-01]
  6. Department discretional funds
  7. UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/R007829/1]
  8. BBSRC [BB/R007829/1] Funding Source: UKRI

向作者/读者索取更多资源

Nanomedicine has become structurally complex, leading to challenges in reliability, uniformity, and reproducibility. This study focuses on leveraging gold nanoclusters to design a versatile drug delivery system that enhances drug elimination and tumor targeting. Additionally, the research uncovers the potential of a drug to suppress tumor growth by stimulating reactive oxygen species production using a smartphone torch.
Nanomedicine has grown structurally complex in order to perform multiple tasks at a time. However, their unsatisfied reliability, uniformity and reproducibility account for the high rates of attrition in translational research. So far, most studies have been one-sidedly focused on the treatment efficacy of inorganic nanoparticles as cancer therapeutics, but overlook their elimination from the body - a key factor in getting regulatory approval. Instead of developing a new drug nanocarrier with uncertain future in medical practice, we therefore choose to leverage the utility of promising and translatable gold nanoclusters (AuNCs) for designing a simple but robust all-in-one nanocluster drug delivery system, where the AuNCs not only strengthen the renal clearance of neutral red (NR) as a model drug, but also aid its passive tumor targeting via the enhanced permeability and retention (EPR) effect. More interestingly, NR can stimulate the production of reactive oxygen species (ROS) to suppress tumor growth under ultralow-level radiation with a smartphone's torch (fluence rate: 8 mW/cm(2)). This finding is especially valuable to low-and middle-income countries lacking resources in healthcare settings. By means of first-principles simulations, we also study in-depth the energies, structural and electronic properties of the AuNCs emitting in the second near-infrared window (NIR-II, 1000-1700 nm). In brief, our model fulfills safety, effectiveness and cost-effectiveness requirements for translational development.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据